Altre lingue Prolight Diagnostics AB

Azioni

PRLD

SE0003618230

Prezzo di chiusura NORDIC GROWTH MARKET Altri mercati azionari 00:00:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
0,325 ^SEK	-12,16%		+98,17%	+7,97%

25/06	Prolight Diagnostics e TTP forniscono un aggiornamento sullo sviluppo di MicroFlex	CI
17/05	Prolight Diagnostics AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Prolight Diagnostics presents the Psyros system at ADLM, one of the world's largest and most important diagnostics congresses	03/07
BioStock: Prolight's partner TTP provides update on MicroFlex development	25/06
Prolight Diagnostics and TTP Provides Update on MicroFlex Development	25/06
Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million	04/06
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million	29/05
BioStock: Prolight Diagnostics strengthens board with experienced business developer	28/05
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024	28/05
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024	27/05
BioStock: Prolight Diagnostics CSO comments on latest data	27/05
Prolight on track for clinical performance studies	23/05
BioStock: Prolight Diagnostics' CTO thrilled to receive UK government grant	21/05
Equity Research \| Prolight Diagnostics: SEK 17m UK grant a welcome external validation	20/05
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant	20/05
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today	20/05
Prolight Diagnostics Gets SEK17 Million Grant to Advance Product Development	17/05
Prolight Diagnostics publishes quarterly report Q1, 2024	17/05
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust	17/05
Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share	16/05
BioStock: Prolight Diagnostics selects partner to conduct clinical validation studies	03/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Prolight Diagnostics AB

Azioni

PRLD

SE0003618230

Altre lingue

Filtri